Other Clinical Trial - Perioperative Hemostasis Management in Liver

Status Not yet recruiting

Clinical Trial Summary

Liver transplantation (LT) is a surgery with risk of bleeding. Several risk factors have been identified: complex dissection, portal hypertension, history of ascites fluid infections, history of surgical procedures, pre-existing complex hemostatic disorders and those acquired during the procedure. Diffuse bleeding can occur at any time during the 3 phases of surgery: dissection, anhepatic and neohepatic. However, intraoperative bleeding and transfusion requirements remain difficult to predict. Current predictive models are based in particular on preoperative characteristics and do not take into account the course and different phases of the operation. The need for transfusions has largely decreased over the last 20 years, and currently around 20-25% of patients are transfused (transfusion of at least 1 blood product during LT). However, massive transfusion is necessary in 10% of LT. The European Society of Anaesthesiology (ESA) has issued recommendations on the management of severe bleeding during surgery. However, these recommendations are not specific to LT. Moreover, transfusion strategies vary widely from one center to another. The implementation of protocols within teams dedicated to LT has led to a reduction in bleeding and transfusion, with or without the use of viscoelastic testing. Intraoperative bleeding and transfusion requirements, as well as postoperative thromboembolic complications, remain difficult to predict. Predictive models of bleeding risk have been developed, but they are based solely on preoperative characteristics and do not take into account the course and various phases of the operation. In addition, new methods such as Bayesian inference or machine learning have been developed, and seem capable of providing different information from that obtained by conventional models. The overall aim of this prospective multicenter observational study is to investigate the risk factors for bleeding and thrombosis in per- and post-operative LT using different predictive methods, and to describe the management of bleeding and post-operative anticoagulation in metropolitan France.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Liver Transplant; Complications

Clinical Trial Details

NCT number	NCT06257407
Study type	Observational
Source	Société Française d'Anesthésie et de Réanimation
Contact	Emmanuel WEISS, MD
Phone	+33 1 40 87 58 81
Email	emmanuel.weiss@aphp.fr
Status	Not yet recruiting
Phase
Start date	March 1, 2024
Completion date	March 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05818644` - Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children
Not yet recruiting	`NCT06041490` - Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation	Phase 2
Recruiting	`NCT04443322` - Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 )	N/A
Recruiting	`NCT05081141` - HHV8 and Solid Organ Transplantation
Completed	`NCT03165916` - Study to Compare the Incidence of Biliary Complications After Liver Transplantation	N/A
Withdrawn	`NCT04216303` - Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus
Recruiting	`NCT04506398` - Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC Recurrence
Not yet recruiting	`NCT05853484` - Home-based Bimodal Lifestyle Intervention in Patients With Liver Cirrhosis Awaiting Orthotopic Liver Transplantation	N/A
Not yet recruiting	`NCT05036031` - Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study
Recruiting	`NCT05065125` - Clinical Usefulness of Digital Single-operator Cholangioscopy(SpyGlass™) for Post-liver Transplant Anastomotic Stricture
Recruiting	`NCT06060392` - Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus	N/A
Enrolling by invitation	`NCT05195944` - Semaglutide vs Sitagliptin	Phase 4
Completed	`NCT05255510` - Risk of Acute Kidney Injury in Living Liver Donor Surgery
Not yet recruiting	`NCT06048445` - Placement of Biliary Drainage Stent to Prevent Biliary Intestinal Anastomosis After Liver Transplantation in Children
Completed	`NCT05116748` - COVID19 Vaccine in SOT Adult Recipients
Completed	`NCT04182256` - Magnetic Spiderman for Preparation of Liver Donation	N/A
Recruiting	`NCT04327427` - Outcome Analysis of Aspirin in Liver Transplantation
Recruiting	`NCT04477967` - Design and Implementation of the Pediatric Liver Transplantation Biobank
Recruiting	`NCT05109156` - Preoperative Sepsis Timeline, Profile and Its Association With Recipient Outcome Following Live Donor Liver Transplant
Recruiting	`NCT06124209` - Use of Fibrin Sealant Patch for Vein Anastomosis During Deceased Donor Liver Transplantation- Randomized Clinical Trial	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Perioperative Hemostasis Management in Liver Transplantation — HEMOTRANSPLANT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms